PSA control following definitive therapy for clinically localized prostate cancer

A. D'Amico, M. Garnick, N. Stone, J. Sylvester, D. Grignon, P. Albertsen, J. Trachtenberg, L. Goldenberg, W. Fair

Research output: Contribution to journalArticle

Abstract

The two goals of treatment for clinically localized prostate cancer are disease control and a good quality of life. At present, the options are radical surgery, conformal or conventional external-beam radiation, and interstitial radiation. This article reviews the effectiveness of these techniques, as judged by serum prostate specific antigen monitoring, with special emphasis on magnetic resonance-guided interstitial brachytherapy.

Original languageEnglish (US)
Pages (from-to)207-215
Number of pages9
JournalMolecular Urology
Volume3
Issue number3
StatePublished - 1999

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'PSA control following definitive therapy for clinically localized prostate cancer'. Together they form a unique fingerprint.

  • Cite this

    D'Amico, A., Garnick, M., Stone, N., Sylvester, J., Grignon, D., Albertsen, P., Trachtenberg, J., Goldenberg, L., & Fair, W. (1999). PSA control following definitive therapy for clinically localized prostate cancer. Molecular Urology, 3(3), 207-215.